This enactment amends the Food and Drugs Act to establish a list of therapeutic products pre-approved for special access to allow streamlined access to treatment for patients with serious or life-threatening conditions or where there is an unmet need. It also provides parameters to guide the Minister of Health in issuing letters of authorization for the sale of new drugs for emergency treatment under the Food and Drug Regulations.
House First Reading
Second reading and referral to committee
House Second Reading
Canada Gazette activity is tracked from January 2025 onward — regulations made before 2025 are not shown.